Fig. 2From: Improved clinical outcome using transarterial chemoembolization combined with radiofrequency ablation for patients in Barcelona clinic liver cancer stage A or B hepatocellular carcinoma regardless of tumor size: results of a single-center retrospective case control studyKaplan-Meier curves of cumulative survival (a) and progression-free survival (PFS) (b) in hepatocellular carcinoma patients with Barcelona Clinic Liver Cancer (BCLC) A/B who received transarterial chemoembolization (TACE) and radiofrequency ablation (RFA) or TACE aloneBack to article page